| scholarly article | Q13442814 |
| P2093 | author name string | A. J. Worth | |
| B. G. Douglas | |||
| P2860 | cites work | Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples | Q24569561 |
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial | Q33453675 | ||
| Controlled study of CCNU and radiation therapy in malignant astrocytoma | Q39968928 | ||
| Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas | Q39986547 | ||
| Glioblastoma multiforme: Treatment with radiation and trhodothyronine | Q40020378 | ||
| Preliminary results using superfractionation in the treatment of glioblastoma multiforme | Q40066325 | ||
| Radiation therapy of brain tumors | Q40847025 | ||
| CHOICE OF VOLUME IN THE X-RAY TREATMENT OF SUPRATENTORIAL GLIOMAS. | Q51283859 | ||
| Implications of the quadratic cell survival curve and human skin radiation "tolerance doses" on fractionation and superfractionation dose selection. | Q52718674 | ||
| Tumor extent as a determining factor in radiotherapy of glioblastomas. | Q55493655 | ||
| A generalized Wilcoxon test for comparing arbitrarily singly-censored samples | Q56428666 | ||
| Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation | Q66890039 | ||
| The use of prognostic factors in predicting survival for breast cancer patients | Q72918257 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| glioblastoma | Q282142 | ||
| P304 | page(s) | 1787-1794 | |
| P577 | publication date | 1982-10-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | Super fractionation in glioblastoma multiforme-results of a phase II study | |
| P478 | volume | 8 |
| Q48926304 | Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors |
| Q70686642 | Acute reactions in rat feet exposed to multiple fractions of X-rays per day |
| Q38845657 | Anaplastic astrocytoma |
| Q44125195 | Anaplastic astrocytoma |
| Q36468064 | Back to the future--radiotherapy in high grade gliomas |
| Q55489042 | Cerebellar glioblastoma in childhood |
| Q55484162 | Cisplatin and etoposide combination therapy for primary glial tumors: Preliminary results |
| Q48490670 | Cisplatin neuropathy in brain tumor chemotherapy |
| Q48421519 | Continuous hyperfractionated accelerated radiotherapy in the treatment of high-grade astrocytomas |
| Q48649116 | Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant glioma cells |
| Q55233326 | Hyperfractionated and Hypofractionated Radiation Therapy for Human Malignant Glioma Xenograft in Nude Mice |
| Q41524743 | Hyperfractionated and accelerated radiation therapy in central nervous system tumors (malignant gliomas, pediatric tumors, and brain metastases) |
| Q49111287 | Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy. |
| Q36347857 | Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Group study |
| Q41482096 | Hyperfractionation: where do we stand? |
| Q36081097 | Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma |
| Q34239497 | Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study |
| Q55485270 | Large dose fraction radiotherapy in the treatment of glioblastoma. |
| Q48632169 | Misonidazole combined with hyperfractionation in the management of malignant glioma |
| Q36078900 | Modified optimal fractionation for poor prognosis malignant gliomas: an elusive search |
| Q36745997 | Multiple fraction-per-day radiotherapy for patients with brain stem tumors |
| Q70686555 | Multiple small fractions per day versus conventional fractionation. Comparison of normal tissue reactions and effect on breast carcinoma |
| Q55483325 | Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas |
| Q36796882 | Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy |
| Q55484778 | Pediatric brainstem glioma. Post-radiation clinical and MR follow-up. |
| Q48649105 | Primary glial tumor patients treated by combining cis-platin and etoposide |
| Q43508591 | Primary treatment of pelvic osteosarcoma. Report of five cases |
| Q39816094 | Radiation oncology. Programs for the present and future |
| Q46096525 | Radiation therapy for brain tumors |
| Q48240589 | Radiation treatment with twice a day fractionation versus conventional fractionation in high grade astrocytoma. A retrospective study |
| Q43742085 | Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas |
| Q55487065 | Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. |
| Q48490574 | The treatment of adult supratentorial high grade astrocytomas |
| Q60547818 | The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options |
Search more.